TETRAVARINEX
LIVE

Serial Number

79132921

Owner

Jazz Pharmaceuticals Research UK Limited

Filing Date

May 30, 2013

Add to watchlist:

No watchlists yet
View on USPTO

TETRAVARINEX Trademark

Serial Number: 79132921 • Registration: 4582222

TETRAVARINEX is a trademark filed by Jazz Pharmaceuticals Research UK Limited on May 30, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Trademark Details

Filing Date

May 30, 2013

Registration Date

August 12, 2014

Published for Opposition

May 27, 2014

Cancellation Date

February 26, 2021

Goods & Services

Pharmaceutical and veterinary pharmaceutical preparations, namely, herbs, herbal extracts, formulas containing herbal extracts, medicinal oils and pure extracts of medicinal plants and herbs, for use in the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes; pharmaceutical and veterinary pharmaceutical preparations for the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes; herbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2025 ADCH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 30, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 28, 2022 INTS
INVALIDATION PROCESSED
Dec 28, 2022 INPC
NEW REPRESENTATIVE AT IB RECEIVED
Nov 24, 2021 NREP
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 9, 2019 REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 12, 2019 REM3
CHANGE OF OWNER RECEIVED FROM IB
Sep 13, 2018 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Dec 21, 2017 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 29, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 29, 2017 REAP
INTERNATIONAL REGISTRATION RENEWED
Dec 15, 2016 RNWL
TOTAL INVALIDATION PROCESSED BY THE IB
Sep 24, 2015 INNT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 19, 2015 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 30, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 6, 2015 FICS
FINAL DISPOSITION PROCESSED
Jan 6, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 12, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2014 R.PR
NOTIFICATION PROCESSED BY IB
Jun 13, 2014 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2014 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2014 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 7, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 7, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2014 NONP
WITHDRAWN FROM PUB - ESU SUPERVISOR REQUEST
Apr 22, 2014 PBPR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 22, 2014 PREV
ASSIGNED TO LIE
Apr 18, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2014 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 2, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 2, 2014 REAP
REFUSAL PROCESSED BY IB
Oct 20, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2013 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 24, 2013 RFCR
NON-FINAL ACTION WRITTEN
Sep 23, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 26, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2013 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 18, 2013 SDRC